Worldwide Over-the-Counter (OTC) Drug Market
Over-the-Counter (OTC) drugs are non-prescription drugs sold to consumers by convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product. There has been a particular focus in the pharmaceutical industry on OTC drugs, and in several market research reports over the past decade, Kalorama Information has covered the strategies pharmaceutical companies are using in the OTC market. This report, The Worldwide Over the Counter (OTC) Drug Market has market sizes and forecasts in five general segments:
Revenues for each segment were generated using dollar and unit sales for key products in each segment and region. The report provides examples of OTC drugs in each general region, segmented as follows:
Issues and trends explored in this study include:
The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. Information is presented as a worldwide overview, with special emphasis on the U.S., Japan, Germany, and other key markets. The market segments provide an overview of demographics, information about products available in each region, market estimates and forecasts. Additionally, a competitive analysis of leading providers and profiles of providers is covered.
In-depth profiles are included for the following companies:
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2007 and 2008, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGRs) are provided for the 2007-2009 and 2009-2014 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2014 was largely based on demographic trends, new developments, and global expansion.
- Analgesics
- Allergy, Cough, Cold, Flu Remedies
- Gastrointestinal Remedies
- Dermatologics
- Others, including
- Smoking Cessation Products
- Sleep Aids
- Hair Growth Remedies
- Diet Aids
Revenues for each segment were generated using dollar and unit sales for key products in each segment and region. The report provides examples of OTC drugs in each general region, segmented as follows:
- Asia Pacific and Africa
- Europe
- North America
- South America
Issues and trends explored in this study include:
- Mergers and Acquisitions
- Distribution and Safety Issues
- Consumer Advertising and Promotion
- Demographics
- World Health and Life Expectancy Trends
- Prescription vs. OTC Industry
- Rx-to-OTC Switch Industry
- Economic Trends
- Health Insurance Issues and Trends
- Consumer Issues and Trends
- Regulatory Environment
- Access to Medicine
The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. Information is presented as a worldwide overview, with special emphasis on the U.S., Japan, Germany, and other key markets. The market segments provide an overview of demographics, information about products available in each region, market estimates and forecasts. Additionally, a competitive analysis of leading providers and profiles of providers is covered.
In-depth profiles are included for the following companies:
- Bayer Consumer Health
- Boehringer Ingelheim
- GlaxoSmithKline
- McNeil Consumer (Johnson & Johnson)
- Merck/Schering-Plough
- Novartis Pharmaceuticals
- Pfizer/Wyeth Consumer
- Procter & Gamble
- Reckitt Benckiser
- Sanofi-Aventis
- Taisho Pharmaceutical
- Takeda
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2007 and 2008, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGRs) are provided for the 2007-2009 and 2009-2014 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2014 was largely based on demographic trends, new developments, and global expansion.
CHAPTER ONE: EXECUTIVE SUMMARY
Background
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting Market
Leading Competitors
CHAPTER TWO: INTRODUCTION
Background
Distribution and Safety Issues in the United States
Consumer Advertising/Promotion
World Health and Life Expectancy
Life Expectancy
Birth Rates
Tobacco Use
Obesity
Declining Growth of the World Population
Prescription VS Over-the-Counter Industry
Rx-to-OTC Switch Industry
Rx-to-OTC Switch Forecast in the United States
Economic Trends
Purchasing Power Trends
U.S. Healthcare Market
U.S. Healthcare Challenges
Health Insurance Issues and Trends
Consumer Issues and Trends
U.S Consumers
Consumers around the World
Access to Professional Medical Services and the Link to Self-Medication
Regulatory Environment
Revisions to Pharmaceutical Affairs Law (PAL) in Japan
Russian Beneficiary Drug Provision Program
A Third Class of Drugs in the United States
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER FOUR: OTC MARKETS IN EUROPE
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
Overview
OTC Product Segment Market Analysis
Markets by Country
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
Overview
Competitor Analysis
Significant Mergers and Acquisitions
Sanofi-Aventis and Chattem Consumer
Schering-Plough and Merck & Co.
Wyeth and Pfizer
Bristol-Myers Squibb and Novartis AG
Johnson & Johnson and Pfizer
Bayer and Roche
Reckitt Benckiser and Adams Respiratory Therapeutics
Reckitt Benckiser and Boots Healthcare
Leading Corporate Profiles
Bayer Healthcare AG
Boehringer Ingelheim GMBH
Glaxo Smith Kline
Mc Neil Consumer
Merck/Schering-Plough
Novartis Consumer
Pfizer/Wyeth
Procter & Gamble
Reckitt Beckiser
Sanofi-Aventis/Chattem
Taisho Pharmaceutical
Takeda Pharmaceutical
APPENDIX
LIST OF MAJOR COMPANIES
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Total World OTC Market Analysis, 2005-2014
Figure 1-1: Total World OTC Market Analysis: 2005-2014
CHAPTER TWO: INTRODUCTION
Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and 2009
Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
Table 2-3: Percent of Smokers by Country
Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions
Table 2-4: Percent of Obese* Population, 2006
Table 2-5: World Population 1980 to 2050
Figure 2-3: World Population 1980 to 2050
Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009
Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009
Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2009
Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2009
Table 2-8: Potential Rx-to-OTC Switches, 2010-2014
Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2006
Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2006
Table 2-10: Gross National Income Comparison by Country 2000-2005
Figure 2-7: Gross National Income Growth by Country 2000-2005
Table 2-11: National Healthcare Expenditures in the United States 1960-2015
Figure 2-8: Healthcare Spending as a Percent of GDP in the United States
Table 2-12: Health Insurance Trends in the United States 2003-2007
Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
Table 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005-2025
Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005, 2015, and 2025
Table 3-1: Total Midyear Population in Africa by Region, 1995-2025
Figure 3-2: Total Midyear Population for Africa by Region, 2005, 2015, and 2025
Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009 and 2014
Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009
Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2014
Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2014
Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2014
Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2014
Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2014
Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2009
Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009
Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009
CHAPTER FOUR: OTC MARKETS IN EUROPE
Table 4-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005-2009
Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005, 2015, and 2025
Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
Table 4-5: European OTC Market as a Percentage of World Market, 2009 and 2014
Figure 4-3: European OTC Market as a Percentage of World Market, 2009
Figure 4-4: European OTC Market as a Percentage of World Market, 2014
Table 4-6: European OTC Market Analysis, 2005-2014
Figure 4-5: European OTC Market Analysis: 2005-2014
Table 4-8: European OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 4-6: European OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 4-7: European OTC Market Analysis by Product Segment, 2009
Table 4-10: European OTC Market Analysis by Selected Country, 2009
Figure 4-8: European OTC Market Analysis by Selected Country, 2009
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
Table 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005-2025
Figure 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005, 2015, and 2025
Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer
Table 5-5: North American OTC Market as a Percentage of World Market, 2009 and 2014
Figure 5-3: North American OTC Market as a Percentage of World Market, 2009
Figure 5-4: North American OTC Market as a Percentage of World Market, 2014
Table 5-6: North American OTC Market Analysis, 2005-2014
Figure 5-5: North American OTC Market Analysis: 2005-2014
Table 5-8: North American OTC Market Analysis by Product Segment, 2005-2014
Figure 5-6: North American OTC Market Analysis by Product Segment, 2005-2014
Figure 5-7: North American OTC Market Analysis by Product Segment, 2009
Table 5-10: North American OTC Market Analysis by Selected Country, 2009
Figure 5-8: North American OTC Market Analysis by Selected Country, 2009
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
Table 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005-2025
Figure 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005, 2015, and 2025
Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
Table 6-5: South American OTC Market as a Percentage of World Market, 2009 and 2014
Figure 6-3: South American OTC Market as a Percentage of World Market, 2009
Figure 6-4: South American OTC Market as a Percentage of World Market, 2014
Table 6-6: South American OTC Market Analysis, 2005-2014
Figure 6-5: South American OTC Market Analysis: 2005-2014
Table 6-8: South American OTC Market Analysis by Product Segment, 2005-2014
Figure 6-6: South American OTC Market Analysis by Product Segment, 2005-2014
Figure 6-7: South American OTC Market Analysis by Product Segment, 2009
Table 6-10: South American OTC Market Analysis by Selected Country, 2009
Figure 6-8: South American OTC Market Analysis by Selected Country, 2009
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
Table 7-1: Total World OTC Market Analysis, 2005-2014
Figure 7-1: Total World OTC Market Analysis: 2005-2014
Table 7-3: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 7-2: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 7-3: Total World OTC Market Analysis by Product Segment, 2009
Figure 7-4: Total World OTC Market Analysis by Product Segment, 2014
Table 7-5: Top Ten World OTC Markets by Country, 2009
Figure 7-5: Top Ten World OTC Markets by Country, 2009
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
Table 8-1: Leading Suppliers Shares of the OTC Market by Estimated Revenues—2007, 2008, and 2009
Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007
Figure 8-2: Leading Suppliers Shares of the OTC Market, 2008
Figure 8-3: Leading Suppliers Shares of the OTC Market, 2009
Background
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting Market
Leading Competitors
CHAPTER TWO: INTRODUCTION
Background
Distribution and Safety Issues in the United States
Consumer Advertising/Promotion
World Health and Life Expectancy
Life Expectancy
Birth Rates
Tobacco Use
Obesity
Declining Growth of the World Population
Prescription VS Over-the-Counter Industry
Rx-to-OTC Switch Industry
Rx-to-OTC Switch Forecast in the United States
Economic Trends
Purchasing Power Trends
U.S. Healthcare Market
U.S. Healthcare Challenges
Health Insurance Issues and Trends
Consumer Issues and Trends
U.S Consumers
Consumers around the World
Access to Professional Medical Services and the Link to Self-Medication
Regulatory Environment
Revisions to Pharmaceutical Affairs Law (PAL) in Japan
Russian Beneficiary Drug Provision Program
A Third Class of Drugs in the United States
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER FOUR: OTC MARKETS IN EUROPE
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
Overview
OTC Product Segment Market Analysis
Markets by Country
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
Overview
Competitor Analysis
Significant Mergers and Acquisitions
Sanofi-Aventis and Chattem Consumer
Schering-Plough and Merck & Co.
Wyeth and Pfizer
Bristol-Myers Squibb and Novartis AG
Johnson & Johnson and Pfizer
Bayer and Roche
Reckitt Benckiser and Adams Respiratory Therapeutics
Reckitt Benckiser and Boots Healthcare
Leading Corporate Profiles
Bayer Healthcare AG
Boehringer Ingelheim GMBH
Glaxo Smith Kline
Mc Neil Consumer
Merck/Schering-Plough
Novartis Consumer
Pfizer/Wyeth
Procter & Gamble
Reckitt Beckiser
Sanofi-Aventis/Chattem
Taisho Pharmaceutical
Takeda Pharmaceutical
APPENDIX
LIST OF MAJOR COMPANIES
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Total World OTC Market Analysis, 2005-2014
Figure 1-1: Total World OTC Market Analysis: 2005-2014
CHAPTER TWO: INTRODUCTION
Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and 2009
Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
Table 2-3: Percent of Smokers by Country
Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions
Table 2-4: Percent of Obese* Population, 2006
Table 2-5: World Population 1980 to 2050
Figure 2-3: World Population 1980 to 2050
Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009
Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009
Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2009
Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2009
Table 2-8: Potential Rx-to-OTC Switches, 2010-2014
Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2006
Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2006
Table 2-10: Gross National Income Comparison by Country 2000-2005
Figure 2-7: Gross National Income Growth by Country 2000-2005
Table 2-11: National Healthcare Expenditures in the United States 1960-2015
Figure 2-8: Healthcare Spending as a Percent of GDP in the United States
Table 2-12: Health Insurance Trends in the United States 2003-2007
Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
Table 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005-2025
Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005, 2015, and 2025
Table 3-1: Total Midyear Population in Africa by Region, 1995-2025
Figure 3-2: Total Midyear Population for Africa by Region, 2005, 2015, and 2025
Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009 and 2014
Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009
Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2014
Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2014
Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2014
Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2014
Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2014
Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2009
Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009
Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009
CHAPTER FOUR: OTC MARKETS IN EUROPE
Table 4-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005-2009
Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005, 2015, and 2025
Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
Table 4-5: European OTC Market as a Percentage of World Market, 2009 and 2014
Figure 4-3: European OTC Market as a Percentage of World Market, 2009
Figure 4-4: European OTC Market as a Percentage of World Market, 2014
Table 4-6: European OTC Market Analysis, 2005-2014
Figure 4-5: European OTC Market Analysis: 2005-2014
Table 4-8: European OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 4-6: European OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 4-7: European OTC Market Analysis by Product Segment, 2009
Table 4-10: European OTC Market Analysis by Selected Country, 2009
Figure 4-8: European OTC Market Analysis by Selected Country, 2009
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
Table 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005-2025
Figure 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005, 2015, and 2025
Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer
Table 5-5: North American OTC Market as a Percentage of World Market, 2009 and 2014
Figure 5-3: North American OTC Market as a Percentage of World Market, 2009
Figure 5-4: North American OTC Market as a Percentage of World Market, 2014
Table 5-6: North American OTC Market Analysis, 2005-2014
Figure 5-5: North American OTC Market Analysis: 2005-2014
Table 5-8: North American OTC Market Analysis by Product Segment, 2005-2014
Figure 5-6: North American OTC Market Analysis by Product Segment, 2005-2014
Figure 5-7: North American OTC Market Analysis by Product Segment, 2009
Table 5-10: North American OTC Market Analysis by Selected Country, 2009
Figure 5-8: North American OTC Market Analysis by Selected Country, 2009
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
Table 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005-2025
Figure 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005, 2015, and 2025
Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
Table 6-5: South American OTC Market as a Percentage of World Market, 2009 and 2014
Figure 6-3: South American OTC Market as a Percentage of World Market, 2009
Figure 6-4: South American OTC Market as a Percentage of World Market, 2014
Table 6-6: South American OTC Market Analysis, 2005-2014
Figure 6-5: South American OTC Market Analysis: 2005-2014
Table 6-8: South American OTC Market Analysis by Product Segment, 2005-2014
Figure 6-6: South American OTC Market Analysis by Product Segment, 2005-2014
Figure 6-7: South American OTC Market Analysis by Product Segment, 2009
Table 6-10: South American OTC Market Analysis by Selected Country, 2009
Figure 6-8: South American OTC Market Analysis by Selected Country, 2009
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
Table 7-1: Total World OTC Market Analysis, 2005-2014
Figure 7-1: Total World OTC Market Analysis: 2005-2014
Table 7-3: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 7-2: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014
Figure 7-3: Total World OTC Market Analysis by Product Segment, 2009
Figure 7-4: Total World OTC Market Analysis by Product Segment, 2014
Table 7-5: Top Ten World OTC Markets by Country, 2009
Figure 7-5: Top Ten World OTC Markets by Country, 2009
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
Table 8-1: Leading Suppliers Shares of the OTC Market by Estimated Revenues—2007, 2008, and 2009
Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007
Figure 8-2: Leading Suppliers Shares of the OTC Market, 2008
Figure 8-3: Leading Suppliers Shares of the OTC Market, 2009
